To describe differences in the immune response to SARS-CoV-2 infection in children and adults
To define distinctive immunopathological signatures that characterize acute SARS-CoV-2 infection and multisystem inflammatory response in children (MIS-C)
To list therapeutic interventions that - if administered in a timely fashion - may ameliorate the inflammatory response associated with MIS-C
